This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: All India exam, Subject name: Pharmacology
Patisiran was approved by FDA recently for 
Select and explain. 
A. Filariasis, B. Peripheral Neuropathy, C. Neuropathy of diabetes, D. Neuropathy of amyloidosis
D: Neuropathy of amyloidosis
Answer: D: Neuropathy of amyloidosis 
Explanation: It is a double stranded small interfering ribose neuclic acid ( si RNA) formulated in the form of a lipid complex. used in the treatment of polyneuropathy